Allscripts Healthcare Solutions (MDRX) 11.54 $MDRX
Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.24 (-0.12), PRSC: 38.48 (-0.90), FNGN: 31.39 (-9.43), LACO: 6.91 (-1.23), MSON: 11.80 (-2.44), SLXP: 91.47 (-47.08), FNHC: 26.14 (+0.04), MDRX: 11.54 (-2.01), PCMI: 7.45 (-3.15), UBNT: 28.78 (-5.84), PFMT: 7.04 (-1.61), ICPT: 172.59 (-74.39), ANDE: 54.79 (+2.83), ACTA: 16.52 (+0.62)
Allscripts Healthcare Solutions Set to Possibly Rebound After Yesterday's Selloff of 14.83%
Comtex SmarTrend(R) - Fri Nov 07, 3:57PM CST
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded in a range yesterday that spanned from a low of $11.00 to a high of $11.76. Yesterday, the shares fell 14.8%, which took the trading range below the 3-day low of $13.40 on volume of 16.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MDRX: 11.54 (-2.01)
Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), MDRX: 11.54 (-2.01), MRGE: 3.06 (+0.03)
Allscripts Healthcare Solutions (MDRX) Stock Lower After Earnings Miss
at The Street - Fri Nov 07, 9:20AM CST
Allscripts Healthcare Solutions (MDRX) is falling Friday after missing analysts' estimates for earnings and revenue in the third quarter.
MDRX: 11.54 (-2.01)
AllScripts Healthcare reports 3Q loss
AP - Thu Nov 06, 5:44PM CST
CHICAGO (AP) — Allscripts Healthcare Solutions Inc. on Thursday posted lower-than-expected third-quarter results and the stock of the electronic health records company tumbled in extended trading.
MDRX: 11.54 (-2.01)
Allscripts announces third quarter 2014 results
PR Newswire - Thu Nov 06, 3:01PM CST
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) ("Allscripts"
today announced its financial results for the three and nine months ended September 30, 2014.
MDRX: 11.54 (-2.01)
Downtrend Call Working As Allscripts Healthcare Solutions Stock Falls 12.9% (MDRX)
Comtex SmarTrend(R) - Thu Nov 06, 9:33AM CST
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 3 months, Allscripts Healthcare Solutions has returned 12.92% as of today's recent price of $13.49.
MDRX: 11.54 (-2.01)
Etransmedia Wins Multi-Million Dollar Award against Allscripts Healthcare in High-Profile Deceptive Business Practice Case
GlobeNewswire - Thu Nov 06, 4:56AM CST
After a hard-fought trial, Etransmedia Technology, Inc. won a decisive victory when an arbitration panel in Raleigh, North Carolina ruled that Allscripts Healthcare, LLC (NASDAQ: MDRX), with offices in Chicago, and Raleigh, NC, had breached its partner agreement with Etransmedia, and violated the North Carolina Unfair and Deceptive Trade Practices Act.
MDRX: 11.54 (-2.01)
Allscripts launches new mobile acute care solution
M2 - Thu Oct 30, 7:37AM CDT
Allscripts (NASDAQ: MDRX) said it has introduced Sunrise Mobile Care, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.
MDRX: 11.54 (-2.01)
Allscripts launches new mobile acute care solution designed for nursing professionals
CNW Group - Wed Oct 29, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has introduced Sunrise Mobile CareTM, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.
MDRX: 11.54 (-2.01)
Cerner Sees In-Line Q3 Earnings but Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:50AM CDT
For the fourth quarter of 2014, Cerner Corporation (CERN) anticipates revenues between $880 and $915 million
QSII: 14.56 (-0.34), MDRX: 11.54 (-2.01), CERN: 63.01 (-0.87), ATHN: 123.82 (-1.94)
Healthcare IT Sparks Sales At Quality Systems, But Profit Drops
Todd Campbell, The Motley Fool - Motley Fool - Thu Oct 23, 8:24AM CDT
Healthcare providers appetite for technology that allows for the electrification of patient health records, practice and processes, and data analytics led to 9% year-over-year sales growth for Quality Systems in its fiscal second quarter ending...
QSII: 14.56 (-0.34), MDRX: 11.54 (-2.01)
Allscripts and ScriptSave team up to deploy innovative prescription savings program
PR Newswire - Thu Oct 23, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has announced that it has partnered with prescription savings solutions provider ScriptSave to deploy innovative capabilities that can promote patient adherence.
MDRX: 11.54 (-2.01)
15.5% Return Seen to Date on SmarTrend Allscripts Healthcare Solutions Call (MDRX)
Comtex SmarTrend(R) - Tue Oct 21, 9:38AM CDT
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 3 months, Allscripts Healthcare Solutions has returned 15.47% as of today's recent price of $13.09.
MDRX: 11.54 (-2.01)
Global Medication Management Market 2014-2019 - Systems, Services & Mode of Delivery Analysis of the $1.6 Billion Industry
M2 - Mon Oct 20, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9vjmrp/medication) has announced the addition of the "Medication Management Market by Systems, Services, Mode of Delivery - Global Forecast to 2019" report to their offering. The global medication management market is valued at an estimated $845.1 million in 2014 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach $1,624.9 million by 2019 The adoption of medication management solutions by healthcare providers is increasing, owing to the rising concerns for minimizing adverse drug events and related medication errors. This is one of the key factors driving the growth of this market in the forecast period. Government initiatives to improve quality of care for patients and reduce healthcare expenditure are also expected to support the growth of the market in the coming years. The global market is broadly segmented by systems, services, mode of delivery, and end-users. The software market is divided into computerized physician order entry, clinical decision support systems, administration software, inventory management software, automated dispensing systems, and assurance systems software. The market, by services, is divided into medication analytics, point-of-care verification, and ADE (adverse drug events) surveillance. The end-users market is segmented into hospitals, pharmacies, and others. The market, by mode of delivery, is divided into on-premises, web-based, and cloud-based models. In 2013, the North American market dominated the global medication management market with a share of 63.7%, followed by Europe, APAC, and RoW. The APAC region shows the maximum growth potential in the coming few years. The urgent need for modernization of healthcare infrastructure, owing to the growth in aging population and increasing incidences of chronic diseases will help drive this market. Countries such as South Korea, China, and Singapore are expected to steer the growth of the medication management market in the APAC region. CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), and Siemens Healthcare (Germany) are some of the top players in the global medication management market. Report Scope By Software - Computerized Physician Order Entry - Clinical Decision Support System - Administration Software - Electronic Medication Administration Record (EMAR) - Barcode Medication Administration (BMA) - Inventory Management - Automated Dispensing Systems (ADS) - Centralized - Robots - Carousels - Decentralized Automated Dispensing Systems - Pharmacy-based ADS - Ward-based ADS - Automated Unit-Dose Dispensing - Assurance System Software By Services - Medication Analytics - Point-of-Care Verification - ADE Surveillance By End-users - Hospitals - Pharmacy - Others By Mode of Delivery - On-premises - Web-based - Cloud-based Companies Mentioned - Allscripts Healthcare Solutions, Inc. - Carefusion Corporation - Cerner Corporation - GE Healthcare (A Division Of General Electric Company) - Mckesson Corporation - Meditech - Omnicell, Inc. - Optum Inc. - Quadramed Corporation - Siemens Healthcare (Subsidiary Of Siemens Ag) For more information visit http://www.researchandmarkets.com/research/9vjmrp/medication
GE: 26.41 (+0.05), MCK: 199.32 (-3.34), MDRX: 11.54 (-2.01), OMCL: 31.89 (-0.28), CERN: 63.01 (-0.87)
Allscripts FollowMyHealth Achieve now generally available; leverages consumer devices for better population health management
PR Newswire - Thu Oct 09, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has announced the market launch and general availability of Allscripts FollowMyHealth(TM) Achieve, a consumer-friendly, patient engagement innovation intended to mobilize and empower patients as active partners in the management of their care.
MDRX: 11.54 (-2.01)
Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.24 (-0.12), PRSC: 38.48 (-0.90), FNGN: 31.39 (-9.43), LACO: 6.91 (-1.23), MSON: 11.80 (-2.44), SLXP: 91.47 (-47.08), FNHC: 26.14 (+0.04), MDRX: 11.54 (-2.01), PCMI: 7.45 (-3.15), UBNT: 28.78 (-5.84), PFMT: 7.04 (-1.61), ICPT: 172.59 (-74.39), ANDE: 54.79 (+2.83), ACTA: 16.52 (+0.62)
Allscripts Healthcare Solutions Set to Possibly Rebound After Yesterday's Selloff of 14.83%
Comtex SmarTrend(R) - Fri Nov 07, 3:57PM CST
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded in a range yesterday that spanned from a low of $11.00 to a high of $11.76. Yesterday, the shares fell 14.8%, which took the trading range below the 3-day low of $13.40 on volume of 16.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MDRX: 11.54 (-2.01)
Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), MDRX: 11.54 (-2.01), MRGE: 3.06 (+0.03)
Allscripts Healthcare Solutions (MDRX) Stock Lower After Earnings Miss
at The Street - Fri Nov 07, 9:20AM CST
Allscripts Healthcare Solutions (MDRX) is falling Friday after missing analysts' estimates for earnings and revenue in the third quarter.
MDRX: 11.54 (-2.01)
AllScripts Healthcare reports 3Q loss
AP - Thu Nov 06, 5:44PM CST
CHICAGO (AP) — Allscripts Healthcare Solutions Inc. on Thursday posted lower-than-expected third-quarter results and the stock of the electronic health records company tumbled in extended trading.
MDRX: 11.54 (-2.01)
Allscripts announces third quarter 2014 results
PR Newswire - Thu Nov 06, 3:01PM CST
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) ("Allscripts"
today announced its financial results for the three and nine months ended September 30, 2014. MDRX: 11.54 (-2.01)
Downtrend Call Working As Allscripts Healthcare Solutions Stock Falls 12.9% (MDRX)
Comtex SmarTrend(R) - Thu Nov 06, 9:33AM CST
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 3 months, Allscripts Healthcare Solutions has returned 12.92% as of today's recent price of $13.49.
MDRX: 11.54 (-2.01)
Etransmedia Wins Multi-Million Dollar Award against Allscripts Healthcare in High-Profile Deceptive Business Practice Case
GlobeNewswire - Thu Nov 06, 4:56AM CST
After a hard-fought trial, Etransmedia Technology, Inc. won a decisive victory when an arbitration panel in Raleigh, North Carolina ruled that Allscripts Healthcare, LLC (NASDAQ: MDRX), with offices in Chicago, and Raleigh, NC, had breached its partner agreement with Etransmedia, and violated the North Carolina Unfair and Deceptive Trade Practices Act.
MDRX: 11.54 (-2.01)
Allscripts launches new mobile acute care solution
M2 - Thu Oct 30, 7:37AM CDT
Allscripts (NASDAQ: MDRX) said it has introduced Sunrise Mobile Care, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.
MDRX: 11.54 (-2.01)
Allscripts launches new mobile acute care solution designed for nursing professionals
CNW Group - Wed Oct 29, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has introduced Sunrise Mobile CareTM, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.
MDRX: 11.54 (-2.01)
Cerner Sees In-Line Q3 Earnings but Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:50AM CDT
For the fourth quarter of 2014, Cerner Corporation (CERN) anticipates revenues between $880 and $915 million
QSII: 14.56 (-0.34), MDRX: 11.54 (-2.01), CERN: 63.01 (-0.87), ATHN: 123.82 (-1.94)
Healthcare IT Sparks Sales At Quality Systems, But Profit Drops
Todd Campbell, The Motley Fool - Motley Fool - Thu Oct 23, 8:24AM CDT
Healthcare providers appetite for technology that allows for the electrification of patient health records, practice and processes, and data analytics led to 9% year-over-year sales growth for Quality Systems in its fiscal second quarter ending...
QSII: 14.56 (-0.34), MDRX: 11.54 (-2.01)
Allscripts and ScriptSave team up to deploy innovative prescription savings program
PR Newswire - Thu Oct 23, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has announced that it has partnered with prescription savings solutions provider ScriptSave to deploy innovative capabilities that can promote patient adherence.
MDRX: 11.54 (-2.01)
15.5% Return Seen to Date on SmarTrend Allscripts Healthcare Solutions Call (MDRX)
Comtex SmarTrend(R) - Tue Oct 21, 9:38AM CDT
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 3 months, Allscripts Healthcare Solutions has returned 15.47% as of today's recent price of $13.09.
MDRX: 11.54 (-2.01)
Global Medication Management Market 2014-2019 - Systems, Services & Mode of Delivery Analysis of the $1.6 Billion Industry
M2 - Mon Oct 20, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9vjmrp/medication) has announced the addition of the "Medication Management Market by Systems, Services, Mode of Delivery - Global Forecast to 2019" report to their offering. The global medication management market is valued at an estimated $845.1 million in 2014 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach $1,624.9 million by 2019 The adoption of medication management solutions by healthcare providers is increasing, owing to the rising concerns for minimizing adverse drug events and related medication errors. This is one of the key factors driving the growth of this market in the forecast period. Government initiatives to improve quality of care for patients and reduce healthcare expenditure are also expected to support the growth of the market in the coming years. The global market is broadly segmented by systems, services, mode of delivery, and end-users. The software market is divided into computerized physician order entry, clinical decision support systems, administration software, inventory management software, automated dispensing systems, and assurance systems software. The market, by services, is divided into medication analytics, point-of-care verification, and ADE (adverse drug events) surveillance. The end-users market is segmented into hospitals, pharmacies, and others. The market, by mode of delivery, is divided into on-premises, web-based, and cloud-based models. In 2013, the North American market dominated the global medication management market with a share of 63.7%, followed by Europe, APAC, and RoW. The APAC region shows the maximum growth potential in the coming few years. The urgent need for modernization of healthcare infrastructure, owing to the growth in aging population and increasing incidences of chronic diseases will help drive this market. Countries such as South Korea, China, and Singapore are expected to steer the growth of the medication management market in the APAC region. CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), and Siemens Healthcare (Germany) are some of the top players in the global medication management market. Report Scope By Software - Computerized Physician Order Entry - Clinical Decision Support System - Administration Software - Electronic Medication Administration Record (EMAR) - Barcode Medication Administration (BMA) - Inventory Management - Automated Dispensing Systems (ADS) - Centralized - Robots - Carousels - Decentralized Automated Dispensing Systems - Pharmacy-based ADS - Ward-based ADS - Automated Unit-Dose Dispensing - Assurance System Software By Services - Medication Analytics - Point-of-Care Verification - ADE Surveillance By End-users - Hospitals - Pharmacy - Others By Mode of Delivery - On-premises - Web-based - Cloud-based Companies Mentioned - Allscripts Healthcare Solutions, Inc. - Carefusion Corporation - Cerner Corporation - GE Healthcare (A Division Of General Electric Company) - Mckesson Corporation - Meditech - Omnicell, Inc. - Optum Inc. - Quadramed Corporation - Siemens Healthcare (Subsidiary Of Siemens Ag) For more information visit http://www.researchandmarkets.com/research/9vjmrp/medication
GE: 26.41 (+0.05), MCK: 199.32 (-3.34), MDRX: 11.54 (-2.01), OMCL: 31.89 (-0.28), CERN: 63.01 (-0.87)
Allscripts FollowMyHealth Achieve now generally available; leverages consumer devices for better population health management
PR Newswire - Thu Oct 09, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has announced the market launch and general availability of Allscripts FollowMyHealth(TM) Achieve, a consumer-friendly, patient engagement innovation intended to mobilize and empower patients as active partners in the management of their care.
MDRX: 11.54 (-2.01)
